Metformin increases the vaccine's effectiveness against cancer

The results of some of the latest studies show that Metformin, a very common diabetes medicine, can help increase the effectiveness of cancer vaccines.

Tests on mice showed that Metformin, used to treat type 2 diabetes, helped the "T" cells in the body work more efficiently.

These cells, which prevent disease in the body, can "remember" previous infections or vaccinations and help them fight off diseases.

Metformin medicine.(Photo: Internet)

A report by a group of American scientists, published in Nature, suggests that Metformin seems to help improve this memory ability many times. The ability to remember the disease has been the subject of many research projects, but so far no one knows about the cell structure of this ability.

The team at McGill University and the University of Pennsylvania used a cancer vaccine to inject into mice. They found that antidiabetic drugs appear to improve the use of this cancer vaccine.

Many recent studies have shown that people with diabetes may be able to detect some types of cancer easily, although the relationship between the two forms is unknown.

Type 2 diabetes is thought to be related to the body's weight gain as well as some forms of cancer, and there are many similarities between the basic chemical reactions that occur inside cells when affected by these diseases.

Dr. Russell Jones of Goodman Cancer Center at McGill University, one of the authors of the article in Nature, said: "Many genes involved in regulating diabetes also play a role. There are also many facts that suggest that people with diabetes are susceptible to certain types of cancer, but our conclusion is that the first studies show that When we aim to metabolize the body in people with diabetes, we can understand the functions of our body's immune system. "

This can help the body fight cancer more effectively with the vaccine. Cancer vaccines are currently only in their infancy, but may eventually prevent cancer from developing or treating when they are new.

Dr Kat Amey of the Institute of Cancer Research in the UK said: "This is an interesting study, it gives us a better understanding of the complex relationship between the immune system, the metabolism. inside cells and cancer ".

Currently research is only done in mice, so it takes a lot of time before it can be applied to cancer patients. However, scientists believe that this research will certainly have many promises in the future.